How to get Topamax fast in New York

If you’re struggling with binge eating disorder (BED), you’re not alone—and you may be wondering if you can access treatment conveniently through telehealth. The short answer is yes. In 2026, telehealth has become a legitimate, safe, and often more accessible way to get evaluated and treated for BED, including receiving prescription medications that can help manage symptoms.

This comprehensive guide will walk you through everything you need to know about getting BED treatment online: what medications are available via telehealth, how federal and state laws support this care, who can prescribe these treatments, and what to expect from a quality telehealth provider.

Understanding Binge Eating Disorder and Treatment Options

Binge Eating Disorder is the most common eating disorder in the United States. It’s characterized by recurrent episodes of eating large quantities of food rapidly, feeling out of control during these episodes, and experiencing significant distress afterward—without the purging behaviors seen in bulimia.

To meet diagnostic criteria, according to the DSM-5, you must experience binge eating episodes at least once weekly for three months, along with three or more of the following: eating much more rapidly than normal, eating until uncomfortably full, eating large amounts when not physically hungry, eating alone due to embarrassment, or feeling disgusted, depressed, or guilty afterward.

Treatment for BED typically involves a combination of approaches:

• Psychotherapy (particularly cognitive-behavioral therapy or dialectical behavior therapy)
• Nutritional counseling
• Medications to help reduce binge frequency and address underlying mental health factors
• Support groups and lifestyle modifications

While the only FDA-approved medication specifically for BED is lisdexamfetamine (Vyvanse)—a controlled stimulant with strict prescribing requirements—healthcare providers commonly prescribe other effective medications ‘off-label’ for BED treatment. The two most commonly prescribed medications via telehealth are topiramate (Topamax) and bupropion (Wellbutrin), both non-controlled substances that can legally be prescribed through telemedicine nationwide.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Why Telehealth Works for BED Treatment

Telehealth offers several advantages for people seeking BED treatment:

Accessibility: You can connect with specialized providers regardless of your geographic location. This is particularly valuable if you live in an area with limited mental health or eating disorder specialists.

Privacy and comfort: For many people with BED, the shame and embarrassment associated with the condition makes it difficult to seek in-person treatment. Telehealth allows you to receive care in the privacy of your own home.

Scheduling flexibility: Telehealth appointments often offer more flexible scheduling, including evening and weekend options that accommodate work schedules.

Continuity of care: If you travel frequently or relocate, telehealth can maintain your treatment continuity with the same provider.

Reduced barriers: No commute time, no waiting rooms, and often lower costs make telehealth more accessible for many people.

Federal Laws Governing Telehealth Prescribing

Understanding the legal framework helps clarify what’s possible with telehealth treatment. At the federal level, the key legislation is the Ryan Haight Act of 2008, which regulates the prescription of controlled substances via telemedicine. This law was designed to prevent illegal online pharmacies from distributing addictive medications without proper medical oversight.

Here’s the critical distinction: The Ryan Haight Act only applies to controlled substances (Schedule II-V drugs like opioids, stimulants, and certain anxiety medications). Medications like topiramate and bupropion are not controlled substances, which means they were never subject to these restrictions in the first place.

During the COVID-19 pandemic, the DEA implemented emergency flexibilities allowing even controlled substances to be prescribed via telehealth without an initial in-person visit. These flexibilities have been extended multiple times and currently remain in effect through December 31, 2026. However, for the non-controlled medications used to treat BED, no special waivers or extensions were ever needed—telehealth prescribing has always been legally permissible at the federal level.

Current Federal Status (2026)

This means that from a federal perspective, healthcare providers can prescribe topiramate or bupropion for BED via telehealth without any mandatory in-person visit, as long as they follow standard medical practices and are licensed in your state.

State-by-State Telehealth Prescribing Rules

While federal law sets the baseline, individual states can impose additional requirements. The good news is that most states have either permanently adopted telehealth-friendly policies or have minimal restrictions for non-controlled medications.

States with No In-Person Requirements

California leads the way in telehealth accessibility. As of 2025, California law explicitly states that prescribing medications via telehealth—even through asynchronous (questionnaire-based) methods—is acceptable as long as it meets the appropriate standard of care. There’s no mandatory in-person examination for non-controlled substances.

New York similarly allows full telehealth prescribing for non-controlled medications. While New York implemented a 2025 rule requiring in-person exams before prescribing controlled substances, this doesn’t affect BED medications like topiramate or bupropion.

Texas, Florida, Delaware, Michigan, Wisconsin, and South Carolina all permit telehealth prescribing of non-controlled medications without mandating in-person visits, as long as providers conduct an appropriate evaluation (which can be done via video or telehealth).

States with Periodic In-Person Requirements

A handful of states require periodic in-person follow-up visits for continued telehealth care:

Alabama requires that if a patient has more than four telehealth visits in a 12-month period for the same condition, an in-person examination must occur within that year. However, this can be satisfied by any collaborating provider—not necessarily the telehealth prescriber.

Georgia asks providers to attempt at least one annual in-person examination for patients receiving ongoing telemedicine care, though the initial evaluation can be conducted entirely via telehealth.

New Hampshire recently updated its laws (effective August 2025) to allow telehealth prescribing even for some controlled medications, but requires an in-person follow-up within 12 months for continued treatment.

These periodic requirements typically don’t prevent you from starting treatment via telehealth—they just mean that at some point during ongoing care, you may need an in-person visit with a local provider for continuity.

Who Can Prescribe BED Medications via Telehealth?

Several types of licensed healthcare providers can evaluate you for BED and prescribe appropriate medications through telehealth:

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathy can prescribe BED medications in all 50 states via telehealth, subject to state-specific requirements. They have full prescribing authority for both controlled and non-controlled substances.

Nurse Practitioners (NPs)

The landscape for NP practice has evolved significantly. As of 2025, 34 states plus Washington D.C. grant nurse practitioners full practice authority, meaning they can evaluate patients and prescribe medications independently without physician oversight.

States granting NP full practice authority include:

• Recently added (2023-2025): Louisiana, Kansas, Wisconsin, Michigan
• Established FPA states: California, New York, New Hampshire, Delaware, Colorado, Arizona, and many others

In these states, an NP working for a telehealth platform like Klarity Health can independently evaluate you for BED and prescribe topiramate or bupropion without requiring a physician’s involvement.

In states without full practice authority (like Texas, Florida, Georgia, and Alabama), NPs must work under a collaborative agreement with a physician. This doesn’t typically affect your care experience—it’s a behind-the-scenes regulatory requirement. You’ll still receive quality care from the NP, with physician oversight built into the practice structure.

Physician Assistants (PAs)

Physician assistants can prescribe non-controlled medications in all states, though they work under the supervision of a collaborating physician. Like NPs in collaborative states, PAs provide excellent care within their scope of practice and can effectively treat BED via telehealth.

Medications Available for BED via Telehealth

Let’s examine the two most commonly prescribed medications for BED that are accessible through telehealth:

Topiramate (Topamax)

What it is: Topiramate is an anticonvulsant medication FDA-approved for preventing seizures and migraines. It’s used off-label for BED based on clinical evidence showing it can reduce binge frequency and support weight management.

How it works for BED: Topiramate appears to reduce impulsive eating behaviors and may decrease appetite. Studies have shown it can significantly reduce weekly binge episodes.

Typical dosing: Providers usually start with a low dose (25mg daily) and gradually increase to find the optimal therapeutic dose (often 100-200mg daily). This ‘start low, go slow’ approach minimizes side effects.

Common side effects: Cognitive changes (word-finding difficulty, mental fog), tingling in hands/feet, carbonated beverages tasting flat, and potential weight loss.

Important precautions:

• Pregnancy: Topiramate is strongly linked to birth defects, particularly cleft palate. Women of childbearing age should use effective contraception.
• Kidney stones: Stay well-hydrated to reduce risk.
• Discontinuation: Must be tapered gradually rather than stopped suddenly to prevent seizures.

Telehealth accessibility: ✅ Fully available—topiramate is not a controlled substance and can be prescribed via telehealth in all states without special restrictions.

Bupropion (Wellbutrin)

What it is: Bupropion is an atypical antidepressant FDA-approved for treating depression and supporting smoking cessation. It’s commonly prescribed off-label for BED.

How it works for BED: Bupropion affects dopamine and norepinephrine, which may help regulate mood and reduce the reward-seeking behavior associated with binge eating. Some patients also experience reduced appetite.

Typical dosing: Usually started at 150mg daily (extended-release), with potential increase to 300mg daily depending on response and tolerability.

Common side effects: Insomnia, dry mouth, headache, nausea, and potential increase in energy/anxiety.

Important precautions:

• Contraindicated in eating disorders with purging: The FDA label specifically warns against using bupropion in patients with current or recent bulimia or anorexia due to increased seizure risk. However, BED (without purging) is generally considered safe.
• Seizure risk: Higher doses increase seizure risk; avoid in patients with seizure disorders.
• Black box warning: Like all antidepressants, carries a warning about increased suicide risk in patients under 25—close monitoring is essential when starting treatment.
• Alcohol: Avoid alcohol use, which can further lower seizure threshold.

Telehealth accessibility: ✅ Fully available—bupropion is not a controlled substance and can be prescribed nationwide via telehealth.

Medication Comparison Table

What to Expect from a Quality Telehealth BED Evaluation

A legitimate telehealth evaluation for BED should be thorough and patient-centered. Here’s what quality care looks like:

Comprehensive Initial Assessment (30-60 minutes)

Your provider will ask detailed questions about:

• Eating patterns: Frequency and nature of binge episodes, triggers, duration of symptoms
• Mental health history: Depression, anxiety, trauma, other eating disorders
• Medical history: Current conditions, medications, previous treatments
• Lifestyle factors: Sleep, exercise, stress levels, support system
• Goals and preferences: What you hope to achieve with treatment

Expect to discuss specific behaviors, such as eating an unusually large amount of food within a two-hour period while feeling unable to stop, and experiencing distress about these episodes at least weekly.

Diagnostic Criteria Review

Your provider will assess whether you meet DSM-5 criteria for BED. This includes confirming:

• Recurrent binge eating episodes
• Eating more rapidly than normal during episodes
• Eating until uncomfortably full
• Eating when not physically hungry
• Eating alone due to embarrassment
• Feeling disgusted, depressed, or guilty afterward
• Marked distress about binge eating
• Episodes occurring at least once weekly for three months
• Absence of regular compensatory behaviors (purging, fasting, excessive exercise)

Safety Screening

Quality providers will screen for contraindications to specific medications:

• History of seizures or epilepsy (affects both medications)
• Current or recent bulimia/anorexia (contraindication for bupropion)
• Pregnancy status or plans (topiramate risks)
• Current medications (checking for interactions)
• Substance use patterns
• Suicidal ideation (important for any antidepressant)

Treatment Plan Discussion

Your provider should discuss:

• Medication options with risks and benefits of each
• The concept of off-label prescribing and why it’s appropriate
• Expected timeline for seeing results
• Potential side effects and how to manage them
• The importance of combining medication with therapy/counseling
• Follow-up schedule and monitoring plan

Informed Consent

You’ll be asked to consent to:

• Telehealth treatment and its limitations
• Off-label medication use
• Privacy practices and electronic communication
• Treatment plan and medication risks

A reputable provider will never rush this process. If you feel pressured or if the evaluation takes less than 15-20 minutes, that’s a red flag.

Understanding Off-Label Prescribing

Both topiramate and bupropion are prescribed ‘off-label’ for BED, meaning they’re used for a condition other than their FDA-approved indication. This is completely legal, common, and often represents the standard of care.

Why off-label prescribing is appropriate for BED:

• The only FDA-approved BED medication (Vyvanse) is a controlled stimulant with strict prescribing requirements and potential for abuse
• Clinical research supports the effectiveness of topiramate and bupropion for BED
• Professional medical organizations recognize these medications as treatment options
• Off-label prescribing allows physicians to use their clinical judgment based on evidence

What this means for you:

• Your insurance may or may not cover off-label uses (varies by plan)
• Your provider should clearly explain why they’re recommending a specific medication
• You have the right to ask questions and discuss alternatives
• The medication itself is FDA-approved and safe—just being used for a different purpose than originally approved

Quality telehealth providers will be transparent about off-label use and ensure you understand and consent to the treatment approach.

Who Should NOT Use Telehealth for BED Treatment?

While telehealth is appropriate for many people with BED, certain situations require in-person evaluation or make you ineligible for specific medications:

Medical Contraindications

Cannot receive bupropion (Wellbutrin):

• Current or recent history of bulimia or anorexia nervosa
• History of seizures or epilepsy
• Taking MAO inhibitors or recently discontinued them
• Abrupt discontinuation of alcohol or sedatives

Cannot receive topiramate (Topamax):

• Pregnancy or planning pregnancy in near future
• Unwilling or unable to use effective contraception (women of childbearing age)
• Severe kidney disease
• History of kidney stones (relative contraindication)

Clinical Situations Requiring In-Person Care

• Severe medical instability: Uncontrolled diabetes, very high blood pressure, recent cardiac events
• Acute suicidality: Active suicidal ideation with plan/intent requires immediate in-person psychiatric evaluation
• Severe malnutrition or electrolyte imbalances: May need medical monitoring
• Comorbid active substance use disorder: Often requires more intensive treatment
• Need for controlled medications: If evaluation suggests you need Vyvanse or other controlled substances for optimal treatment
• Complex medical conditions: Multiple serious conditions requiring frequent physical exams

Red Flags About the Provider

Avoid telehealth services that:

• Promise medication before completing a thorough evaluation
• Don’t ask detailed questions about your symptoms and history
• Pressure you to start treatment immediately
• Don’t discuss therapy or other treatment options alongside medication
• Offer to prescribe controlled stimulants online (Vyvanse, Adderall) without proper safeguards
• Don’t verify your identity and location
• Charge suspiciously low fees with no transparency

If any of these apply, seek a more reputable telehealth provider. Quality services like Klarity Health prioritize thorough evaluations, evidence-based treatment, and patient safety.

Prescription Monitoring and Follow-Up Care

Prescription Monitoring Programs (PMPs)

Many states maintain Prescription Drug Monitoring Programs that track controlled substance prescriptions. Because topiramate and bupropion are not controlled substances, most states don’t require providers to check the PMP before prescribing them.

However, responsible providers may voluntarily check your prescription history to:

• Ensure you’re not receiving duplicate prescriptions from multiple providers
• Identify potential drug interactions
• Verify medication history you’ve reported
• Practice due diligence in patient care

Don’t be concerned if your provider mentions checking the PMP—it’s a sign of thorough, careful practice.

Ongoing Monitoring and Follow-Up

Initial phase (first 4-8 weeks):

• Expect follow-up appointments every 2-4 weeks
• Provider will assess medication tolerance and effectiveness
• Dose adjustments may be made
• Side effects will be addressed
• Binge frequency should be tracked

Maintenance phase:

• Follow-up appointments typically every 1-3 months
• Ongoing assessment of treatment effectiveness
• Monitoring for side effects or complications
• Discussion of therapy progress and lifestyle modifications
• Medication adjustments as needed

Laboratory monitoring:

• Baseline labs may be ordered (metabolic panel, kidney function, pregnancy test)
• Periodic monitoring of kidney function on topiramate
• Blood pressure checks on bupropion

Refill Policies

Because these are non-controlled medications, providers can typically prescribe:

• Up to 90-day supplies with multiple refills
• Refills valid for 6-12 months depending on state regulations
• Automatic pharmacy transfers for mail-order or preferred pharmacies

Some states (like Alabama, Georgia, New Hampshire) may require periodic in-person visits (typically within 6-12 months) for continued telehealth prescribing, even for non-controlled medications. Your provider will inform you of any such requirements.

Insurance Coverage and Costs

Telehealth Parity Laws

Most states now have ‘telehealth parity’ laws requiring insurance companies to cover telehealth visits the same way they cover in-person visits. This means:

• Same copay/coinsurance as office visits
• Cannot refuse coverage solely because care was delivered via telehealth
• Applies to both video and audio-only visits (in many states)

Medication Coverage

Coverage for off-label medications varies by insurance plan:

• Some plans cover any FDA-approved medication regardless of the condition being treated
• Other plans only cover medications for FDA-approved uses
• Prior authorization may be required for off-label prescribing

Generic versions of both topiramate and bupropion are available and typically cost much less than brand names:

• Generic topiramate: Often $10-30/month
• Generic bupropion: Often $10-40/month
• Without insurance: Costs vary but usually under $50/month for generics

Cash-Pay Options

Many telehealth platforms, including Klarity Health, offer transparent cash-pay pricing for patients without insurance or those whose plans don’t cover telehealth. Benefits include:

• Predictable, upfront pricing
• No surprise bills or hidden fees
• Often faster access to appointments
• Privacy (no insurance claims filed)

Typical cash-pay costs:

• Initial evaluation: $150-300
• Follow-up visits: $75-150
• Medication: $10-50/month (generics without insurance)

How Klarity Health Supports BED Treatment

Klarity Health offers a patient-centered approach to mental health care, including treatment for Binge Eating Disorder. Here’s what sets quality telehealth providers apart:

Provider Availability

Access to licensed psychiatric providers (MDs, DOs, NPs, PAs) across multiple states means you can get care quickly, often within days rather than waiting weeks or months for a traditional appointment.

Transparent Pricing

Whether you’re using insurance or paying cash, you’ll know the cost upfront—no surprise bills or hidden fees. This transparency helps you make informed decisions about your care.

Insurance and Cash-Pay Flexibility

Klarity Health accepts most major insurance plans while also offering affordable cash-pay options. This flexibility ensures cost isn’t a barrier to getting the help you need.

Comprehensive Care Approach

Quality providers don’t just prescribe medication—they discuss the importance of therapy, nutritional support, and lifestyle modifications. Many platforms can connect you with therapists, dietitians, or support groups to complement medication management.

Ongoing Support

Between appointments, you should have access to secure messaging or nurse support for questions about side effects, medication refills, or concerns that arise. This continuity of care is essential for successful BED treatment.

Safety and Quality Considerations in Telehealth

The rapid expansion of telehealth during the pandemic brought increased scrutiny—and deservedly so. High-profile cases of telehealth companies prioritizing profit over patient safety (such as the ADHD telehealth company whose executives were indicted for unsafe stimulant prescribing practices) have highlighted the importance of choosing reputable providers.

What Quality Telehealth Looks Like

Thorough evaluations: Initial appointments should be 30+ minutes with comprehensive history-taking

Licensed providers: All prescribers should be licensed in your state and have appropriate credentials

Evidence-based treatment: Recommendations should align with clinical guidelines and research

Informed consent: Clear explanation of risks, benefits, alternatives, and off-label use

Appropriate prescribing: Refusal to prescribe when not clinically indicated; emphasis on combination treatment approaches

Secure technology: HIPAA-compliant platforms for video visits and messaging

Coordination of care: Willingness to communicate with your other providers (with your permission)

Clear policies: Transparent pricing, refund policies, and treatment limitations

Warning Signs of Low-Quality Providers

• Prescriptions promised before evaluation
• Minimal or no questioning during appointments
• Pressure to start medication immediately
• Prescribing controlled substances without proper safeguards
• No discussion of therapy or other treatment modalities
• Refusal to provide written treatment plans
• Selling medications directly rather than sending prescriptions to pharmacies
• No licensed provider involvement (only automated questionnaires)

State-Specific Considerations

While telehealth for BED medications is widely accessible, some state-specific factors may affect your care:

States with Enhanced Telehealth Access

California: Leading telehealth flexibility, including asynchronous (questionnaire-based) prescribing when appropriate

New York: Full telehealth prescribing for non-controlled substances; NPs have independent practice authority

Delaware: Explicitly allows telemedicine for medication-assisted treatment and other psychiatric care

Wisconsin & Michigan: Recently expanded NP scope; strong telehealth infrastructure

States with Periodic Follow-Up Requirements

Alabama: In-person visit required within 12 months if more than 4 telehealth visits for same condition

Georgia: Annual attempt at in-person examination for ongoing telemedicine patients

New Hampshire: Annual in-person follow-up for continued treatment (as of 2025 updates)

These requirements typically don’t prevent initial telehealth treatment but may require eventually seeing a local provider for a check-up to continue care.

Evolving State Policies

Several states are considering or have recently enacted changes to NP scope of practice and telehealth regulations:

• Alabama & South Carolina: Legislation for NP full practice authority has been discussed but not yet enacted (as of late 2025)
• Texas: Continues to require physician collaboration for NPs/PAs
• Florida: Maintains collaborative practice requirements with some exceptions for certified NPs in primary care

Always verify current requirements in your state, as regulations continue to evolve.

The Future of Telehealth for BED

The regulatory landscape for telehealth continues to stabilize post-pandemic. Key developments to watch:

Federal Rule-Making

The DEA is expected to finalize permanent rules for telehealth controlled substance prescribing by the end of 2026. While this primarily affects controlled medications (not topiramate or bupropion), it will set the long-term framework for telehealth prescribing in general.

State Modernization

More states are permanently adopting telehealth-friendly policies and expanding provider scope of practice. The trend is toward greater access and flexibility rather than restriction.

Quality Standards

Professional organizations and regulatory bodies are developing clearer standards for telehealth quality and safety, which ultimately protects patients while maintaining access.

Technology Advancement

Improvements in remote patient monitoring, asynchronous care platforms, and integrated health records will continue to enhance telehealth effectiveness.

Frequently Asked Questions

Can I get BED medication prescribed at my first telehealth appointment?

Yes, if clinically appropriate. After a thorough evaluation, your provider may prescribe medication at the initial visit. However, they might also recommend starting with therapy or want additional information before prescribing.

Do I need to turn on my camera for the appointment?

Most states and providers require video for the initial evaluation to properly assess your condition. Some states allow audio-only follow-ups once care is established.

What if I’m already seeing a therapist in person?

That’s excellent! Telehealth medication management can complement your ongoing therapy. Your prescriber may request permission to coordinate with your therapist.

Can I use telehealth if I travel frequently or live in multiple states?

Providers must be licensed in the state where you’re physically located during the appointment. Some multi-state platforms have providers licensed in many states to accommodate this.

What happens if the medication doesn’t work or causes side effects?

You should have access to your provider between appointments to discuss concerns. They can adjust the dose, switch medications, or recommend additional interventions.

Will my regular doctor know about my telehealth treatment?

Only if you authorize information sharing. Telehealth records are confidential, but coordinating care with your primary doctor is often beneficial.

Can I get therapy and medication management through the same telehealth platform?

Many platforms, including Klarity Health, can connect you with both prescribers and therapists, allowing comprehensive care through one service.

Taking the Next Step: Starting Your BED Treatment Journey

If you’re considering telehealth treatment for Binge Eating Disorder, here’s how to move forward:

1. Research reputable telehealth providersLook for platforms with:

• Licensed providers in your state
• Transparent pricing
• Good patient reviews
• Clear policies about prescribing practices
• Comprehensive approach to mental health

2. Prepare for your evaluationBefore your appointment, consider:

• Writing down your symptoms and how long you’ve experienced them
• Listing current medications and medical conditions
• Noting any previous treatments you’ve tried
• Preparing questions about treatment options
• Having your pharmacy information ready

3. Be honest and thoroughThe quality of your care depends on the accuracy of information you provide. Don’t minimize symptoms or hide relevant history out of embarrassment—your provider needs complete information to help you safely.

4. Commit to the full treatment planMedication is most effective when combined with therapy, nutritional support, and lifestyle changes. Be prepared to engage with multiple aspects of recovery.

5. Give treatment time to workBoth topiramate and bupropion typically take several weeks to show full effects. Stay in communication with your provider about your progress and any concerns.

Conclusion: Accessible, Quality Care for BED

Telehealth has transformed access to mental health treatment, making it possible for people struggling with Binge Eating Disorder to receive effective, evidence-based care regardless of where they live. The legal framework now supports telehealth prescribing of non-controlled medications like topiramate and bupropion across all 50 states, with only minimal state-specific variations.

Whether you’re just beginning to recognize your struggles with binge eating or you’ve been searching for accessible treatment options, telehealth offers a legitimate pathway to recovery. With thorough evaluations, appropriate prescribing practices, and comprehensive support, quality telehealth providers can deliver the same standard of care you’d receive in a traditional office setting—with added convenience and often faster access.

The key is choosing a reputable provider who prioritizes your safety and takes a comprehensive approach to treatment. Platforms like Klarity Health combine provider availability, transparent pricing, and flexible payment options to remove barriers to getting the help you need.

If you’re ready to take the next step in addressing your Binge Eating Disorder, consider scheduling a telehealth evaluation. With proper treatment, including medication when appropriate, therapy, and support, recovery is possible—and it may be more accessible than you think.

Research Currency Statement

Verified as of: January 4, 2026

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to Ryan Haight Act restrictions on telemedicine. Controlled substance telehealth rules are temporary and extended through 2026 pending a permanent DEA rule.

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

• Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

• Flagged for follow-up: ⚠️ Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Citations

1. HHS Press Release (2026): ‘DEA Extends Telemedicine Flexibilities Through December 31, 2026’ – Official announcement of the fourth extension of COVID-era telehealth prescribing rules. www.hhs.gov

2. Sheppard Mullin Health Law Blog (2025): ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ – Comprehensive legal analysis of state-by-state teleprescribing regulations with statutory citations. www.sheppardhealthlaw.com

3. Center for Connected Health Policy (2025): ‘State Telehealth Laws & Reimbursement Policies: Online Prescribing’ – Official state-by-state database of telehealth regulations, updated November-December 2025. www.cchpca.org

4. Health Jobs Nationwide Blog (2025): ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025)’ – Analysis of nurse practitioner scope of practice changes including 2023-2025 legislative updates. blog.healthjobsnationwide.com

5. DailyMed/FDA (2024): ‘Bupropion Hydrochloride Extended-Release Tablets Label’ – Official FDA-approved prescribing information including contraindications and black box warnings. dailymed.nlm.nih.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12